{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:44:09Z","timestamp":1792701849478,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011002","name":"National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"crossref","award":["81760253"],"award-info":[{"award-number":["81760253"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011002","name":"National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"crossref","award":["81960254"],"award-info":[{"award-number":["81960254"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"crossref","award":["2018FE001(-009)"],"award-info":[{"award-number":["2018FE001(-009)"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To evaluate the association between risperidone use and interleukin-6 (IL-6) levels by conducting a meta-analysis of controlled before-and-after studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Studies were identified through a systematic search of PubMed and Embase. The mean and standardized differences were extracted to calculate the standardized mean differences. IL-6 levels were compared in patients with schizophrenia before and after risperidone treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Ten studies were included in the final meta-analysis. The primary findings from our study suggest that there was a significant decrease in serum IL-6 levels after risperidone treatment (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.021). A subgroup analysis revealed the sources of heterogeneity. The sensitivity analysis indicated that the results were stable, and no publication bias was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The present meta-analysis provides evidence that risperidone can significantly reduce IL-6 levels in schizophrenia. IL-6 is a potential biomarker of the pathophysiology and clinical processes of schizophrenia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019694","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:26:52Z","timestamp":1586550412000},"page":"e19694","source":"Crossref","is-referenced-by-count":19,"title":["Effects of risperidone on blood levels of interleukin-6 in schizophrenia"],"prefix":"10.1097","volume":"99","author":[{"given":"Ziqiao","family":"Feng","sequence":"first","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"You","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Ma","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Long","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Liu","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders and National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Teng","sequence":"additional","affiliation":[{"name":"Kunming Medical University Sixth Affiliated Hospital, Yuxi, Yunnan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrn2054","article-title":"The neuropoietic cytokine family in development, plasticity, disease and injury","volume":"8","author":"Bauer","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000356536","article-title":"First-episode psychosis: an inflammatory state?","volume":"21","author":"Zajkowska","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R9-20230915","first-page":"603","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","volume":"25","author":"Wells","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0924-977X(99)00062-0","article-title":"Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics","volume":"10","author":"Maes","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/00207450108986549","article-title":"Effect of risperidone on serum cytokines","volume":"111","author":"Kim","year":"2001","journal-title":"The International journal of neuroscience"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.intimp.2005.10.004","article-title":"Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines","volume":"6","author":"Pae","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000213565","article-title":"Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients","volume":"59","author":"Kim","year":"2009","journal-title":"Neuropsychobiology"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-008-1447-6","article-title":"Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"204","author":"Zhang","year":"2009","journal-title":"Psychopharmacology"},{"key":"R17-20230915","first-page":"375","article-title":"Increased interleukin-6 level in Taiwanese schizophrenic patients","volume":"34","author":"Lin","year":"2011","journal-title":"Chang Gung medical journal"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2013.03.027","article-title":"Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response","volume":"147","author":"Borovcanin","year":"2013","journal-title":"Schizophrenia research"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2014.01.001","article-title":"Activation of Th17 cells in drug naive, first episode schizophrenia","volume":"51","author":"Ding","year":"2014","journal-title":"Progress in neuro-psychopharmacology and biological psychiatry"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"yu042","DOI":"10.1093\/ijnp\/pyu042","article-title":"Effects of risperidone on cytokine profile in drug-naive first-episode psychosis","volume":"18","author":"Noto","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naive, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","article-title":"Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis","volume":"29","author":"Noto","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/1570159X15666170828170921","article-title":"Neuron-glia interaction as a possible pathophysiological mechanism of bipolar disorder","volume":"16","author":"Pinto","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2015.03.025","article-title":"Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders","volume":"85","author":"Verkhratsky","year":"2016","journal-title":"Neurobiol Dis"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijdevneu.2018.06.001","article-title":"Differential effects of typical and atypical antipsychotics on astroglial cells in vitro","volume":"69","author":"Bobermin","year":"2018","journal-title":"Int J Dev Neurosci"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pnpbp.2012.12.001","article-title":"Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone","volume":"43","author":"De Souza","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1007\/s12035-015-9489-3","article-title":"Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naive first episode psychosis","volume":"53","author":"Noto","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0920-9964(01)00296-1","article-title":"Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology","volume":"57","author":"Xiang","year":"2002","journal-title":"Schizophrenia Research"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fnins.2018.00384","article-title":"Pretreatment with risperidone ameliorates systemic LPS-induced oxidative stress in the cortex and hippocampus","volume":"12","author":"Mamun","year":"2018","journal-title":"Front Neurosci"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","article-title":"The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia","volume":"65","author":"Song","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02900219","article-title":"Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission","volume":"247","author":"Frommberger","year":"1997","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:27:21Z","timestamp":1694816841000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019694"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019694","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}